Paragraf Company Profile

Background

Paragraf, established in 2017 as a spin-off from the University of Cambridge, is a pioneering technology company specializing in the mass production of graphene-based electronic devices using standard semiconductor processes. The company's mission is to revolutionize the electronics industry by integrating graphene—a material renowned for its exceptional conductivity, strength, and flexibility—into commercial applications. Paragraf's vision is to drive a 2D-material revolution in the semiconductor industry, facilitating significant advancements in technology performance across various sectors.

Key Strategic Focus

Paragraf's strategic focus centers on developing and commercializing graphene-based electronic devices that outperform traditional silicon-based components. The company's core objectives include:

Product Innovation: Developing unique offerings such as Graphene Hall Effect Sensors (GHS) and Graphene Field-Effect Transistors (GFETs) that leverage graphene's superior properties.

Market Expansion: Targeting diverse industries, including automotive, industrial automation, cryogenics, healthcare, and agri-tech, to broaden the application of graphene technologies.

Technological Advancement: Utilizing proprietary contamination-free graphene growth processes to ensure high-quality, scalable production compatible with existing semiconductor manufacturing.

Financials and Funding

Paragraf has demonstrated robust financial growth and investor confidence:

Revenue: As of June 2025, the company reported annual revenues of approximately $48.8 million.

Funding: The company has raised a total of $114 million over multiple funding rounds. Notably, in March 2022, Paragraf secured a $60 million Series B funding round led by New Science Ventures, with participation from existing investors such as Parkwalk, Amadeus Capital Partners, IQ Capital, and Molten Ventures, as well as new investors including British Patient Capital and In-Q-Tel. This funding aims to enhance R&D capabilities, expand manufacturing infrastructure, and support international growth.

Pipeline Development

Paragraf's product pipeline includes:

Graphene Hall Effect Sensors (GHS): Currently in production and utilized across aerospace, semiconductor, healthcare, automotive, scientific research, industrial, and quantum computing sectors.

Graphene-Based Biosensors: In development, these sensors aim to transform clinical point-of-care diagnostics in the medical industry, with anticipated market introduction in the near future.

Technological Platform and Innovation

Paragraf's technological edge is defined by:

Proprietary Graphene Growth Process: A contamination-free method that enables the production of high-purity graphene directly onto crystalline substrates like silicon, silicon-carbide, sapphire, and gallium-nitride.

Standard Semiconductor Process Compatibility: Ensuring that graphene-based devices can be integrated seamlessly into existing manufacturing lines.

Product Portfolio: Including Graphene Hall Effect Sensors and Graphene Field-Effect Transistors, offering superior sensitivity, robustness, and energy efficiency.

Leadership Team

Paragraf's leadership comprises experienced professionals:

Dr. Simon Thomas, FREng, CPhys – CEO: With a background in physics, engineering, and materials science, Dr. Thomas has extensive experience in semiconductors and functional materials, leading Paragraf's strategic direction and technological advancements.

Prof. Sir Colin Humphreys, CBE, FREng, FRS – CSO: An expert in materials science, Sir Colin has a history of commercializing scientific ideas and has received numerous international accolades for his research.

Tony Pearce, CEng, BEng, FIMMM – COO: Bringing over 30 years of experience in the semiconductor industry, Mr. Pearce focuses on electronic material processes and volume manufacturing.

Andrew MacInnes, PhD – CDO: With a PhD in Materials Science and extensive experience in product development and volume manufacturing, Dr. MacInnes leads the transformation of Paragraf's core technologies into high-volume products.

Cathy Cranton, MEng, FCA, BFP – CFO: With a master's degree in Aerospace Engineering and a background in finance, Ms. Cranton oversees Paragraf's financial operations and strategic financial planning.

Leadership Changes

In May 2023, Paragraf expanded its leadership team by acquiring Cardea Bio, a leading producer of graphene-based biocompatible chips. This acquisition led to the establishment of Paragraf USA, with the San Diego facility and team becoming integral parts of Paragraf's operations. Michael Heltzen, former CEO and co-founder of Cardea Bio, joined Paragraf as Executive Vice President of Strategy, contributing to the company's strategic initiatives and integration efforts.

Competitor Profile

Market Insights and Dynamics

The global graphene market is experiencing rapid growth, with projections estimating it will reach approximately $1.09 billion by 2025, expanding at a compound annual growth rate (CAGR) of 38.7%. This growth is driven by increasing demand for advanced materials in electronics, energy storage, and sensors.

Competitor Analysis

Paragraf operates in a competitive landscape with several key players:

Graphenea: Based in Spain, Graphenea specializes in the production of high-quality graphene materials and has established partnerships with various research institutions.

Haydale Graphene Industries: A UK-based company focusing on functionalized graphene and nanomaterials, offering solutions across multiple sectors.

Directa Plus: An Italian company producing graphene-based products for textiles, environmental applications, and composites.

These competitors focus on different aspects of the graphene market, from raw material production to specialized applications, contributing to the dynamic and evolving industry landscape.

Strategic Collaborations and Partnerships

Paragraf has established significant collaborations to enhance its market position and innovation capacity:

CERN: Partnering to develop advanced sensors for scientific research applications.

National Physical Laboratory (NPL): Collaborating on the standardization and characterization of graphene materials.

Rolls Royce: Working together to explore graphene applications in aerospace technologies.

Tachmed Ltd: Partnering to develop scalable, cost-effective, and accurate diagnostic testing solutions for home and primary care clinics.

Operational Insights

Paragraf's strategic considerations include:

Market Position: As the first company to mass-produce graphene-based electronic devices using standard semiconductor processes, Paragraf holds a unique position in the market.

Competitive Advantages: The company's proprietary contamination-free graphene growth process and compatibility with existing manufacturing infrastructure provide significant competitive edges.

Challenges: Navigating high capital investment requirements, regulatory hurdles, and the need for continuous innovation to maintain market leadership.

Strategic Opportunities and Future Directions

Paragraf's strategic roadmap includes:

Product Diversification: Expanding the product portfolio to include graphene-based biosensors and other advanced devices.

Market Expansion: Targeting emerging markets such as wearables, IoT devices, and flexible electronics to capture new customer segments.

Technological Innovation: Investing in research and development to enhance existing products and develop new applications for graphene technologies.